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Raymond Leslie White (1943–2018)
Louis J. Pta´cek1,*Raymond Leslie WhiteRaymond Leslie White was born in Orlando, Florida on
October 23rd, 1943, during the second World War. His
dad, Larry, was a navigator on B-29s and his mom, Mar-
jorie, was a belle from an old Florida family. After the
war, they moved back to his father’s hometown of Spring-
field, OR, where Ray grew up hunting and fishing with his
dad and acquired his life-long love of the outdoors and na-
ture. Ray attended college at the University of Oregon. His
mentors in the Department of Microbiology, Frank and
Mary Stahl, and George Striesinger, thought Ray had great
potential as a scientist and supported his application to
MIT, where he subsequently attended graduate school
and received his Ph.D. under the guidance of Maury Fox.
Ray spentmany long days working in the lab, but he also
found some time to enjoy skydiving with his friends. Early
in his stay in Cambridge, he met his future wife, Joan Dis-
tin, who had come to MIT for her first job. They fell in love
at first sight and were engaged to be married 3 months
later. Together, they spent 5 years in Cambridge, along
with many happy weekends in the New England back-
country and in Connecticut, at Joan’s family home.
With a tiny inheritance from Joan’s grandfather, Joan
and Ray bought half ownership of a 2-seater 1946 Lus-
combe and started flying lessons, mostly with Joan’s1Distinguished Professor of Neurology, University of California, San Francisco
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University for Ray’s post-doctoral work with David Hog-
ness, Ray flew the plane across the country, and Joan
would meet him at little airports along the way to camp
out for the night. During their 3 years in Palo Alto, Joan
and Ray engaged in some new, personal genetic experi-
ments—their two children, with whom they eventually
shared many adventurous activities, including flying, sail-
ing, and floating on western rivers.
Ray’s post-doc with Hogness focused on genetics in
Drosophila melanogaster. In 1975, after a very successful
3-year fellowship, Ray moved to the University of Massa-
chusetts School of Medicine to take his first faculty posi-
tion, which lasted 5 years. It was during this time that
Joan began a long and award-winning career as an artist.
In 1980, Ray was recruited to the University of Utah in
the Department of Cellular, Viral, and Molecular Biology.
During this time, his work in genetics continued to evolve
toward more complex organisms (i.e., Homo sapiens).
Later that year, Ray (along with David Botstein, Ron Da-
vis, and Mark Skolnick) published a seminal American Jour-
nal of Human Genetics paper that proposed the systematic
development of anonymous human genetic markers and
their placement into chromosomal maps of the human
genome.1 Part of the attraction ofmoving to the University
of Utah had been the access to a substantial population of
large Mormon families. Ray and his colleagues collected
DNA samples from more than 1,000 individuals in 3-gen-
eration families to use as a mapping panel for the genetic
markers he (and others) had begun to identify and
develop. For a family to be included, there had to be four
living and healthy grandparents, two living and healthy
parents, and a sibship of 10 or more children (the so-called
‘‘10-sib families’’). This was a panel large enough to map
markers with (at the time) exquisite precision. The samples
and cell lines were housed at the Centre d‘Etude du Poly-
morphisme Humain (CEPH), and were the first example
of a distributed resource that enabled broad international
collaboration on a biological problem. Ultimately, the
CEPH families’ samples were used by all of the major
groups involved in building human genetic maps so that
data generated by different groups could all be placed
into the same genomic framework.
In 1984, Ray became chair of the newly formed Depart-
ment of Human Genetics at the University of Utah. In that
same year, at the request of Mortimer Mendelsohn, Ray, San Francisco 94143, USA
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organized a DOE-funded meeting that many now refer to
as the ‘‘Alta Conference.’’ It was held at the Alta ski resort
a short distance from the University of Utah. Always hav-
ing had an incredible eye for talent, Ray invited an extraor-
dinary group of molecular biologists and human geneti-
cists. Ray had a truly unique power of personality that
pushed out the boundaries of this new era in the field of
human genetics. A real crucible, this meeting bubbled
over with excitement and ideas. Many of the young
attendees were destined to become luminaries in their
respective fields. From this meeting, many came away
with a new vision for how human genetics might develop
as a field. Until this point, Homo sapiens presented signifi-
cant problems as a genetic organism. This changed as a
result of Ray White’s daring and creative vision.
Ray’s pioneering work created the foundation for mod-
ern human genetics, and this foundation has transformed
our understanding of virtually every human disease. He
played a seminal role in the technical development of hu-
man genetic maps; his role in collecting the CEPH family
mapping set that was universally employed for map devel-
opment was particularly important. Early on, the only
available markers were restriction-fragment-length poly-
morphisms (RFLPs). Ray’s group identified a new class of
genetic markers that are cleaved by restriction enzymes
to produce fragments of many different lengths.2 This
polymorphism is due to variation in the number of tan-
dem repeats (VNTRs) of a DNA sequence. The VNTRs can
be detected by Southern blotting. Becausemost individuals
will be heterozygous at such loci, these markers are highly
informative for linkage analysis. This discovery set the
stage for subsequent identification of short tandem-repeat
markers (also called microsatellites), which are also highly
polymorphic.
Ray not only developed genomic technology but also
applied it to important medical conditions. In some of
the earliest DNA-marker studies, Ray and his trainee Web
Cavenee, discovered a fundamental mechanism underly-
ing tumor development. They showed that although one
copy of the ‘‘retinoblastoma gene’’ can be inherited (in
an autosomal-dominant fashion), the other is often lost
during tumor development. Ray and Web recognized the
deleted allele as ‘‘loss-of-heterozygosity’’ by referencing
polymorphic markers.3 The family inheritance of suscepti-
bility is dominant, but on a cellular level, the disease is
recessive. This was the first molecular confirmation of
Knudson’s tumor suppressor hypothesis and marked the
realization that many cancer genes act as tumor suppres-
sors. Both copies of the gene are inactivated in cancer cells.
This realization provided the basis for an approach to iden-
tifying a wholly new and important class of tumor genes,
the ‘‘tumor suppressors,’’ which are now known to be crit-
ical in tumorigenesis.
As Ray’s lab developed thousands of genetic markers,
they used the CEPH mapping panel to place them in chro-
mosomal maps of the human genome at ever-increasing
density. They then went on to use these reagents to genet-Theically map many important human disease genes. Ray sub-
sequently focused on two genes: neurofibromin 1 (NF1,
mutations in which cause neurofibromatosis type 1)4,5
and adenomatous polyposis coli (APC, a gene involved in
colon cancer).6 He used positional cloning to identify the
causative genes and mutations in these conditions.7–10
Ray went on to study the in vitro functions of the relevant
proteins and discovered the function of NF1 in regulating
cell growth, revealing the underlying molecular patho-
physiology of this disease through discovery of a key func-
tional domain that had GAP (GTPase activating protein)
activity.11 This discovery meant that the encoded protein
(neurofibromin) was most likely responsible for inhibiting
the activity of Ras proteins, known to be potent mediators
of cellular signaling systems. This subsequently led to the
testing of farnesyl inhibitor drugs in mouse models, and
the drugs were found to improve the cognitive disorders
associated with NF1 mutations. This offered hope for
new therapeutic approaches for treating neurofibroma-
tosis.12 Ray was therefore a pioneer at every step in the cen-
tral human genetic paradigm, and his work transformed
the field of human genetics in a way that revolutionized
biomedical and translational research. His discovery of
NF1 and APC, and subsequent molecular characterization
of the implicated proteins, provided the foundation
upon which all subsequent genetic disease studies
now rest.
In 1990, the Human Genome Project was launched.
Ray’s (and others’) genetic markers and maps were used
for building physical maps of large insert clones, which
were then shot-gun subcloned and sequenced. Thus,
Ray’s genetic mapping efforts were also foundational to
the Human Genome Project.
Ray had a rare capacity to lead in both the lab and the
cultural and political arenas of academic leadership. With
Ray Gesteland, he was responsible for building the Eccles
Institute of Human Genetics at the University of Utah. In
addition to housing the Department of Human Genetics,
the Institute also housed a new incubator program for Hu-
man Molecular Biology and Genetics (the brainchild of
Ray, Steve Prescott, and Michael Simmons). In 1994, Ray
became the Chairman of the Department of Oncological
Sciences at the University of Utah and became the found-
ing Director of the new Huntsman Cancer Institute. In
2002, believing the time was right to embark on the chal-
lenging road of complex genetics, he moved to the Univer-
sity of California, San Francisco School of Medicine. There,
until his health began to fail, he served as the Director of
the Ernest Gallo Clinic and Research Center, the Rudi
Schmid Distinguished Professor in neurology, and Vice
Chair of the Department of Neurology.
In reading through Ray’s bibliography, one notes that he
has trained many leaders in their respective fields. Ray also
generously supported and mentored many individuals
with whom he never shared authorship. During my own
time as a fellow in his lab, Ray edited every paper I wrote
and, at the end, removed his name from the author list.American Journal of Human Genetics 104, 8–10, January 3, 2019 9
He did this despite having made fundamental intellectual
contributions, not tomention offering financial support to
acquire reagents for all of my experiments. I am just one
example of the many trainees and mentees who have
benefited from Ray’s generous and selfless mentorship.
His impact on the field of human genetics has thus been
even greater thanmight be imagined simply from perusing
his own publication record.
In recognition of his accomplishments, Ray was elected
to the National Academy of Sciences (1992), the American
Academy of Arts and Sciences (2005), and the National
Academy of Medicine (2005). He received many awards,
including the American Society of Human Genetics Allan
Award (1989),13 the General Motors Cancer Research
Foundation Charles S. Mott Prize (1990), and the National
Health Council’s National Medical Research Award (1991),
to name a few.
Ray’s presence in the field will be greatly missed. He was
a giant amongmen, amaverick alwaysmoving toward new
horizons and into new areas, where he frequently made
monumental contributions. Though gone now, Ray will
remain among us, having left a legacy of people whom
he trained and mentored and who are now leaders in
many areas of biomedical science. His genes will continue
to segregate in his wonderful and loving family and,
through them and his trainees, he will continue to make
our world a better place.
Ray is predeceased by his son Jon Robert White (by a pre-
vious marriage) and by his parents, Larry and Margorie
White. He is survived by his wife, Joan; his daughter Juli-
ette Palmer White (married to Jon Owen); his son Jeremy
Distin White (married to Skylin); his daughter Anne Marie
White (by a previous marriage); his grandsons, William
Distin Owen and Benjamin Griffin Owen; and his sisters,
Susan Mckenzie, Ruth Germaine, and Athalia White.
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